99mTc‐labeled, tofacitinib citrate encapsulated chitosan microspheres loaded in situ gel formulations for intra‐articular treatment of rheumatoid arthritis

Documenti analoghi

• Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data
  di: Ali Ekin, et al.
  Pubblicazione: (2024)
• Safety outcomes of tocilizumab and tofacitinib treatment for rheumatoid arthritis: Target trial emulation
  di: Yao‐Fan Fang, et al.
  Pubblicazione: (2024)
• Flare risk after oral glucocorticoid bridging with methotrexate or intra‐articular bridging with triple therapy in early rheumatoid arthritis
  di: Kristina Lend, et al.
  Pubblicazione: (2026)
• Trajectory of lipid profiles in rheumatoid arthritis patients receiving tofacitinib: Evidence from the prospective CENTRA cohort
  di: Hong Huang, et al.
  Pubblicazione: (2026)
• Treatment of [99mTc]Tc‐hydroxy‐diphosphonate ([99mTc]Tc‐HDP) extravasation using hyaluronidase
  di: Kevin R. Doornhof, et al.
  Pubblicazione: (2024)